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Abstract
According to Davey et al. (2011) with a total of 22,453 meta-analyses from
the January 2008 Issue of the Cochrane Database of Systematic Reviews, the
median number of studies included in each meta-analysis is only three. In other
words, about a half or more of meta-analyses conducted in the literature include
only two or three studies. While the common-effect model (also referred to as
the fixed-effect model) may lead to misleading results when the heterogeneity
among studies is large, the conclusions based on the random-effects model may
also be unreliable when the number of studies is small. Alternatively, the fixed-
effects model avoids the restrictive assumption in the common-effect model and
the need to estimate the between-study variance in the random-effects model.
We note, however, that the fixed-effects model is under appreciated and rarely
used in practice until recently. In this paper, we compare all three models
and demonstrate the usefulness of the fixed-effects model when the number of
studies is small. In addition, we propose a new estimator for the unweighted
average effect in the fixed-effects model. Simulations and real examples are also
used to illustrate the benefits of the fixed-effects model and the new estimator.
Keywords: Common-effect model, Effect size, Fixed-effect model, Fixed-effects
model, Meta-analysis, Random-effects model
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1 Introduction
Meta-analysis is a quantitative method for synthesizing results from multiple inde-
pendent studies. Through combining the randomized trials of the same comparison
of interventions, the estimates of correlation between two variables, or the measures
of the accuracy of a diagnostic test, meta-analysis can help researchers to understand
inter-study differences, to compare multiple treatments simultaneously, and, more
generally, to synthesize evidence from different types of studies (Berkey et al., 1995;
Hunter and Schmidt, 2004; Lu and Ades, 2004; Ades and Sutton, 2006; Leeflang et al.,
2008; Borenstein et al., 2011). According to Web of Science Core Collection as of 12
December 2019, there are more than 186,600 publications in the literature with the
keyword of “meta-analyses” in the title or abstract. Without any doubt, meta-analysis
has become one of the most important areas in medical research.
There are two commonly used models in meta-analysis: the common-effect model
and the random-effects model. The common-effect model, also known as the fixed-
effect model, assumes one common effect across all the studies, denoted by the com-
mon effect. In contrast, the random-effects model assumes that the true effect sizes
may vary from study to study but they follow a certain distribution, e.g. a normal
distribution. The summary effect in the random-effects model is known as the mean
effect, which is the mean of the underlying distribution.
According to Davey et al. (2011) with a total of 22,453 meta-analyses from the
January 2008 Issue of the Cochrane Database of Systematic Reviews, the median num-
ber of studies included in each meta-analysis is only three. In other words, about a half
or more of meta-analyses conducted in the literature include only two or three studies.
For meta-analysis with few studies in the presence of heterogeneity, the common-effect
model and the random-effects model are likely to yield misleading or unreliable re-
sults (Hedges and Vevea, 1998; Poole and Greenland, 1999; Henmi and Copas, 2010;
Gonnermann et al., 2015; Röver et al., 2015; Bender et al., 2018). On one hand, when
the observed effect sizes have large differences, the common-effect model often has
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an inflated type I error rate and provides a poor coverage probability for estimated
confidence interval of the common effect. On the other hand, the estimate of the
mean effect in the random-effects model relies heavily on the between-study variance
estimate. For meta-analysis with few studies, however, it is unlikely to have a reliable
estimate for the between-study variance(Cornell et al., 2014).
In addition to the two common models, there is another model available for meta-
analysis termed as the fixed-effects model (Laird and Mosteller, 1990; Hedges and Vevea,
1998). The fixed-effects model assumes that the effect sizes of the studies are deter-
ministic and different. That is, it neither assumes the study-specific effect sizes to
be all the same as in the common-effect model, nor requires them to follow a certain
distribution as in the random-effects model. For meta-analysis with few studies, the
fixed-effects model is capable to provide a good balance between the common-effect
model and the random-effects model. It not only avoids the unreasonable assumption
on a common effect in the common-effect model when the heterogeneity exists, but
also avoids the low accuracy of the between-study variance estimate in the random-
effects model when there are only few studies.
For the fixed-effects model, two summary effects have been suggested in the liter-
ature: the unweighted average effect (Laird and Mosteller, 1990; Bender et al., 2018)
and the weighted average effect (Rice et al., 2018). The summary effects selection
should depend on the research goal of the meta-analysis. If all the studies are re-
graded as equally important, the unweighted average effect by Laird and Mosteller
(1990) should be used. We note that the summary effects and conclusions for the
fixed-effects models are pertaining to the observed studies only. The estimator of the
weighted average effect proposed by Rice et al. (2018) is the same as the estimator
of the common effect in the common-effect model. For the unweighted average effect,
the existing unbiased estimator by Laird and Mosteller (1990) does not fully utilize
the information across the studies.
In this paper, we demonstrate that the fixed-effects model can serve as the most
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convincing model for meta-analysis with few studies through real examples. For the
unweighted average effect in the fixed-effects model, in addition to the unweighted
average, we propose a new estimator with different weight for each study that fully
utilizes the information across the studies. Through theory and simulation, we demon-
strate that our optimal estimator performs better than the unweighted average esti-
mator in all settings in the sense of having minimal mean squared error.
The rest of the paper is organized as follows. In Section 2, we review the three
models for meta-analysis. In Section 3, we propose an optimal estimator for the
unweighted average effect and assess its performance through numerical studies. In
Section 4, we illustrate the usefulness of the fixed-effects model using real examples.
Finally, we conclude the paper with a brief discussion in Section 5, and provide the
technical results in the Appendix.
2 Existing models for meta-analysis
The common-effect model and the random-effects model are two most popular models
for meta-analysis. They were first introduced in the 1950s (Bliss, 1952; Cochran,
1954), and have now been widely adopted for synthesizing multiple studies. The fixed-
effects model was introduced in Laird and Mosteller (1990) and Hedges and Vevea
(1998), but received little attention until recently (Bender et al., 2018; Rice et al.,
2018). In this section, we provide a brief review on the three models, including
their model assumptions, their effect sizes, and their key limitations in performing a
meta-analysis.
2.1 Common-effect model
The common-effect model assumes that all the studies share a common effect, for
which we denote it by θ. In other words, as shown in Figure 1(a), the differences in
the observed effect sizes are all subject to sampling errors. Mathematically, we can
4
(a) Common−effect model
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(b) Fixed−effects model
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µ
Figure 1: Schematics of the three models for meta-analysis: the common-effect model,
the fixed-effects model, and the random-effects model. The squares represent the
observed effect sizes, the diamonds represent the study-specific effect sizes, and the
circles represent the summary effects.
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express the common-effect model as
yi = θ + εi, εi
ind
∼ N(0, σ2i ), (1)
where yi are the observed effect sizes, θ is the common effect, εi are the random errors
for studies i = 1, . . . , k, and k is the total number of studies. In addition, the random
errors εi are assumed to be normally distributed with zero mean and variances σ
2
i > 0,
where “ind” represents the random errors are independent of each other. To avoid
confusion with the “fixed-effects” model in Figure 1(b) or more specifically in Section
2.3, we refrain from using the fixed-effect model, but refer to model (1) consistently
as the common-effect model throughout the paper.
With model (1), the common effect can be unbiasedly estimated as
θˆ =
∑k
i=1 w
C
i yi∑k
i=1 w
C
i
,
where wCi = 1/σ
2
i are the study-specific weights that are derived by minimizing the
mean squared error (MSE) of θˆ (Laird and Mosteller, 1990). For ease of reference, we
have also provided a detailed derivation of the study-specific weights in Appendix A.
A study with a large sample size will more likely yield a small study-specific variance,
and consequently, a large weight will be assigned to that study to quantify the level
of reliability.
Further by the normality assumption on the random errors, θˆ follows a normal
distribution with mean θ and variance 1/
∑k
i=1 w
C
i ; and accordingly, a 95% confidence
interval (CI) of θ is [θˆ−1.96/
√∑k
i=1 w
C
i , θˆ+1.96/
√∑k
i=1 w
C
i ]. Note that the estimates
of the within-study variances are treated as true variances to compute the common
effect and its CI.
2.2 Random-effects model
In many studies, the differences between the observed effect sizes can be relatively
large such that they are not able to be explained fully by sampling errors. Such
differences are well known as the heterogeneity of the studies. The heterogeneity
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may arise from various aspects, including, for example, the different designs in ex-
periments or the different covariants in the model regression (Brockwell and Gordon,
2001). When such a scenario occurs, a common effect for all the studies is unlikely
to be true; and consequently, if model (1) is still applied, it often yields underesti-
mated standard errors of the estimated common effects and confidence intervals with
insufficient coverage.
To account for the heterogeneity of the studies, as shown in Figure 1(c), a random-
effects model is often considered by assuming the study-specific effect sizes also follow
an underlying distribution, e.g., a normal distribution. To be more specific, the
random-effects model can be expressed as
yi = µ+ ζi + εi, ζi
i.i.d.
∼ N(0, τ 2), εi
ind
∼ N(0, σ2i ), (2)
where yi are the observed effect sizes, µ is the mean effect, ζi are the deviations of
the study-specific effect sizes from the mean effect, and εi are the random errors.
We further assume that the deviations ζi are independent and identically distributed
(i.i.d.) from N(0, τ 2), the random errors εi are the same as in model (1), and they are
independent of each other. In addition, we refer to τ 2 as the between-study variance
and σ2i as the within-study variances.
With model (2), if τ 2 is known, the mean effect can be unbiasedly estimated as
µˆ =
∑k
i=1 w
R
i yi∑k
i=1 w
R
i
,
where wRi = 1/(σ
2
i + τ
2) are the study-specific weights that are derived by minimizing
the MSE of µˆ (Laird and Mosteller, 1990). For a detailed derivation of the study-
specific weights, please refer to Appendix B. For the special case when τ 2 = 0, the
random-effects model reduces to the common-effect model. Further by the normality
assumptions on both the effect sizes and the random errors, we have µˆ following a
normal distribution with mean µ and variance 1/
∑k
i=1 w
R
i ; and accordingly, a 95% CI
of µ is [µˆ−1.96/
√∑k
i=1 w
R
i , µˆ+1.96/
√∑k
i=1 w
R
i ]. Note that the between-study variance
τ 2 is unknown and needs to be estimated from the data. In particular, there exists
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many methods for estimating τ 2 in the literature including the moments estimator, the
likelihood-based estimate, and the empirical Bayes estimate. For a detailed review and
comparison of these existing estimators, one may refer to Sidik and Jonkman (2010),
Veroniki et al. (2016), and the references therein. When few studies are included in
a meta-analysis, a reliable estimate of the between-study variance is hard to achieve
for most existing methods including the Paule and Mandel (1982) method and the
DerSimonian and Laird (1986) method. As illustrated in Section 4, the resulting CI
may be too wide to be useful in practice.
2.3 Fixed-effects model
In the fixed-effects model, the effect size of each study is assumed to be a fixed but
unequal quantity (Ramsey and Schafer, 2012). That is, we neither require the study-
specific effect sizes to be all the same as in model (1), nor assume that they follow a
certain distribution as in model (2). Under these specifications, we can present the
fixed-effects model as
yi = θi + εi, εi
ind
∼ N(0, σ2i ), (3)
where yi are the observed effect sizes, θi are the study-specific effect sizes, and εi are
independent random errors that are normally distributed with zero mean and variance
σ2i > 0. Model (3) is referred to as a fixed-effects model since θi are deterministic
rather than random variables as in model (2).
A major limitation of the fixed-effects model is that it does not provide a clear
summary effect as the common effect in model (1) or the mean effect in model (2).
In other words, there does not exist a clear position to place the circles for the
summary effect, as shown in Figure 2. Two summary effects have been proposed in
the literature. One is the unweighted average effect as defined in Laird and Mosteller
(1990) and Bender et al. (2018), and the other is the weighted average effect as defined
in Rice et al. (2018).
Unweighted Average Effect: For the fixed-effects model, by treating each study as
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(a) Common−effect model
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θ
(b) Fixed−effects model
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θ1 θ2
(c) Random−effects model
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ε2
ζ1
ζ2
µ
Figure 2: Schematics of the three models for meta-analysis: the common-effect model,
the fixed-effects model, and the random-effects model. Unlike the common-effect
model and the random-effects model, the fixed-effects model does not exist a clear
position to place the circles for the summary effect.
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equally important, one natural summary effect is
φu =
1
k
k∑
i=1
θi. (4)
We refer to this summary effect as the unweighted average effect. Following this
definition, Laird and Mosteller (1990) proposed to estimate φu by
φˆu =
1
k
k∑
i=1
yi. (5)
Further by the normality assumption in model (3), φˆu follows a normal distribu-
tion with mean
∑k
i=1 θi/k and variance
∑k
i=1 σ
2
i /k
2, and a 95% CI of φu is [φˆu −
1.96
√∑k
i=1 σ
2
i /k, φˆu + 1.96
√∑k
i=1 σ
2
i /k].
Weighted Average Effect: Allowing the weights to depend on the within-study
variances and the sample sizes, Rice et al. (2018) proposed the weighted average effect
as
φw =
∑k
i=1 ηiγiθi∑k
i=1 ηiγi
=
∑k
i=1
ni∑k
j=1 nj
1
niσ2i
θi
∑k
i=1
ni∑k
j=1 nj
1
niσ2i
=
∑k
i=1 σ
−2
i θi∑k
i=1 σ
−2
i
,
where ni are the sample sizes, ηi = ni/
∑k
j=1 nj are the proportions associated with
each individual study, and γi = 1/(niσ
2
i ) reflect an average rate of information over
the observations from the ith study. They further proposed to estimate the weighted
average effect by
φˆw =
∑k
i=1 σ
−2
i yi∑k
i=1 σ
−2
i
. (6)
Note that φˆw is the same as the unbiased estimator of the common effect θ in the
common-effect model. Under the normality assumption in model (3), φˆw follows a
normal distribution with mean
∑k
i=1 θiσ
−2
i /
∑k
i=1 σ
−2
i and variance 1/
∑k
i=1 σ
−2
i , and a
95% CI of φw is [φˆw − 1.96/
√∑k
i=1 σ
−2
i , φˆw + 1.96/
√∑k
i=1 σ
−2
i ].
3 Optimal estimation for the fixed-effects model
For better application of the fixed-effects model in meta-analysis with few studies,
we propose an optimal estimator for the unweighted average effect in this section.
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We also assess the estimation accuracy of the proposed estimator through numerical
studies.
3.1 Optimal estimator of the unweighted average effect
Note that the common effect estimator θˆ and the mean effect estimator µˆ are both
weighted averages of the observed effect sizes, in which the weights are assigned by
the inverse-variance method. Following the same logic, we propose to estimate the
unweighted average effect φu in (4) by
φ˜u =
∑k
i=1 w
F
i yi∑k
i=1 w
F
i
, (7)
where wFi ≥ 0 are the weights assigned to each individual study. In the special
case when wFi = 1/k for all i = 1, . . . , k, our new estimator φ˜u will be the same as
the unweighted estimator φˆu in (5). It is worth nothing that, even though φˆu is an
unbiased estimator, it does not guarantee to be the optimal estimator for φu.
To derive the optimal weights in (7), we choose to minimize the MSE of φ˜u as
follows:
MSE(φ˜u) = E
(∑k
i=1 w
F
i yi∑k
i=1 w
F
i
− φu
)2
.
We have shown in Appendix C that, when
1 +
k∑
j=1
(θj − θi)(θj − φu)
σ2j
> 0, (8)
for i = 1, . . . , k, there exists a unique positive solution for the optimal weights as
wFi =
1
σ2i

1 + k∑
j=1
(θj − θi)(θj − φu)
σ2j

. (9)
Note that assumption (8) is to guarantee the weights to be positive. When the
assumption does not hold, there is no explicit solution for the optimal weights. In such
settings, the computational methods such as interior point and conjugate gradient can
be used to find the numerical solutions. When k = 2, assumption (8) always holds
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and we have 

wF1 =
1
σ21
+
(θ1 − θ2)
2
2σ21σ
2
2
,
wF2 =
1
σ22
+
(θ1 − θ2)
2
2σ21σ
2
2
.
When k = 3, if assumption (8) holds, the optimal weights can also be expressed as


wF1 =
1
σ21
+
(θ1 − θ2)(θ1 + θ3 − 2θ2)
3σ21σ
2
2
+
(θ1 − θ3)(θ1 + θ2 − 2θ3)
3σ21σ
2
3
,
wF2 =
1
σ22
+
(θ2 − θ1)(θ2 + θ3 − 2θ1)
3σ21σ
2
2
+
(θ2 − θ3)(θ1 + θ2 − 2θ3)
3σ22σ
2
3
,
wF3 =
1
σ23
+
(θ3 − θ1)(θ2 + θ3 − 2θ1)
3σ21σ
2
3
+
(θ3 − θ2)(θ1 + θ3 − 2θ2)
3σ22σ
2
3
.
Compared to the unbiased estimator φˆu in (5), our new estimator φ˜u fully utilizes
the information across the studies, and hence provides a smaller MSE. Specifically,
the bias of our new estimator is
Bias(φ˜u) =
∑k
i=1 w
F
i θi∑k
i=1 w
F
i
−
∑k
i=1 θi
k
.
When θi = θ for all i = 1, . . . , k, it follows that Bias(φ˜u) = 0 and w
F
i = 1/σ
2
i which are
exactly the same as wCi in Section 2.1. That is, when the fixed-effects model reduces
to the common-effect model, our proposed estimator will be exactly the same as the
common effect estimator θˆ in the common-effect model. Note that φ˜u is derived with
minimizing the MSE, which means MSE(φˆu)−MSE(φ˜u) ≥ 0. This leads to
Var(φˆu)− Var(φ˜u) = MSE(φˆu)−MSE(φ˜u) + Bias(φ˜u)
2 ≥ 0,
where the equality holds only if σ21 = · · · = σ
2
k, that is, w
F
i /
∑k
j=1 w
F
j = 1/k so that φ˜u
is the same as φˆu. This shows that our new estimator always has a smaller variance
than the existing estimator. Taking k = 2 as an example, the difference between the
two variances can be expressed as (σ21−σ
2
2)
2[σ21+σ
2
2+2(θ1−θ2)
2]/{[σ21+σ
2
2+(θ1−θ2)
2]2}
which is non-negative with the equality holding only when σ21 = σ
2
2 .
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From another perspective, we note that φ˜u = αφˆw + (1 − α)φˆu where α =∑k
i=1 σ
−2
i /
∑k
i=1 w
F
i . Therefore, the optimal estimator is a weighted average of the un-
weighted average effect estimator φˆu by Laird and Mosteller (1990) and the weighted
average effect estimator φˆw by Rice et al. (2018). When all θi are the same, it reduces
to φˆw in (6). Finally, under the assumptions of the fixed-effects model, φ˜u follows a
normal distribution with mean
∑k
i=1 w
F
i θi/
∑k
i=1 w
F
i and variance
∑k
i=1(w
F
i σi)
2/(
∑k
i=1 w
F
i )
2,
and a 95% CI of φu is [φ˜u−1.96
√∑k
i=1(w
F
i σi)
2/
∑k
i=1 w
F
i , φ˜u+1.96
√∑k
i=1(w
F
i σi)
2/
∑k
i=1 w
F
i ].
3.2 Numerical comparison
Since a half or more of meta-analyses include only two or three studies, we therefore
conduct numerical studies to evaluate the performance of our new estimator for k = 2
and 3. The unbiased estimator φˆu is also considered for comparison to explore how
much improvement that our new estimator can achieve. To visualize the numerical
results, we compute the MSE, the squared bias, and the variance of the two estimators,
and plot them in Figure 3 for k = 2 and in Figure 4 for k = 3.
In the first study with k = 2, we consider the fixed-effects model in (3) with
several different settings of θi and σi. Specifically for the top three plots in Figure 3,
we consider σ1 = 1, σ2 = 2, θ1 = 0, and θ2−θ1 = d with the difference d ranging from
0 to 10; while for the bottom three plots, we consider θ1 = −5, θ2 = 5, σ1 = 1, and
σ2/σ1 = r with the ratio r ranging from 1 to 10. Our second study is with k = 3. For
the top three plots in Figure 4, we consider σ1 = 1, σ2 = 2, σ3 = 3, θ1 = 0, θ2 = 5,
and θ3−θ1 = d with the difference d ranging from 0 to 10; while for the bottom three
plots, we consider θ1 = −10, θ2 = 0, θ3 = 10, σ1 = 1, σ2 = 2, and σ3/σ1 = r with the
ratio r ranging from 1 to 10.
From the numerical results, it is evident that our optimal estimator has a smaller
MSE than the unbiased estimator in all settings for k = 2 and k = 3. It is also evident
that the MSE as the sum of the squared bias and the variance is mainly contributed
by the variance of the estimator. The improvement increases as the difference between
means θi decreases or the ratio between variances σi increases. Note that we have
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also conducted numerical studies for many other settings (not shown to save space),
and the comparison results remain similar as those in Figures 3 and 4. To conclude,
in comparison with the unbiased estimator, our new estimator sacrifices a small bias
for a significant reduction in variance of the estimator so that the MSE decreases.
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Figure 3: Comparison of the two estimators for the unweighted average effect with
k = 2. The red lines with empty circles represent the results of the unbiased estimator
φˆu, and the blue lines with solid circles represent the results of our new estimator φ˜u.
The top three plots represent the results along with the range of d, and the bottom
three plots represent the results along with the range of r.
4 Applications to meta-analysis with few studies
In this section, we apply the fixed-effects model to four real examples in clinical trails,
including studies with both continuous and binary outcomes, and compare them
with the common-effect model and the random-effects model. We compute both the
optimal estimator and the Laird and Mosteller (L-M) estimator for the unweighted
14
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Figure 4: Comparison of the two estimators for the unweighted average effect with
k = 3. The red lines with empty circles represent the results of the unbiased estimator
φˆu, and the blue lines with solid circles represent the results of our new estimator φ˜u.
The top three plots represent the results along with the range of d, and the bottom
three plots represent the results along with the range of r.
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average effect in the fixed-effects model.
4.1 Meta-analysis with two studies
The first example is with Ding et al. (2018), who reported a systematic review about
the association between three genetic variants (rs1058205, rs2735839, and rs266882)
in kallikrein 3 (KLK3) and prostate cancer risk, with the observed effect sizes being
the odds ratios (OR). The genotypes reflected the disease include CC, CT, and TT.
In a subgroup meta-analysis, only two studies are included as shown in Figure 5(a).
The first study indicates a significant association between the rs1058205 TT and CC
(OR = 0.29, CI = 0.19 to 0.43), whereas the second study does not give a significant
result (OR = 0.93, CI = 0.78 to 1.12). Combining the two studies, the common-
effect model gives a significant result for the common effect (OR = 0.77, CI = 0.66 to
0.89). Nevertheless, with the large heterogeneity between the two studies (I2 = 96.5%,
p < 0.001), the assumption of a common effect may not hold so that the meta-analytic
results from the common-effect model may be misleading. On the other hand, the
random-effects model does not provide a significant result for the mean effect with a
wide CI (OR = 0.53, CI = 0.17 to 1.67). In contrast, different from the above two
models, the fixed-effects model does not involve an unstable estimate of the between-
study variance, and meanwhile it does not impose the unrealistic assumption of a
common effect. Specifically, it provides significant results for the unweighted average
effect (the L-M estimator: OR = 0.52, CI = 0.42 to 0.63; the optimal estimator: OR
= 0.53, CI = 0.43 to 0.64), which is very close to the mean effect in the random-effects
model (OR = 0.53); and more importantly, it yields a narrower CI for the unweighted
average effect which is about the same length as that for the the common effect in
the common-effect model.
The second example investigated the effectiveness of interventions for reducing
nonoccupational sedentary behavior in adults and older adults (Shrestha et al., 2019).
As shown in Figure 5(b), the observed effect sizes are the mean differences (MD).
Neither study showed a significant difference between the two groups (study 1: MD
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= -75.2, CI = -153.4 to 3; study 2: MD = -7.5, CI = -32.17 to 17.17). Combining the
two studies, the common-effect model gives a non-significant result for the common
effect (MD = -13.63, CI = -37.15 to 9.9). The random-effects model also does not
have a significant result for the mean effect (MD = -30.76, CI = -93.78 to 33.25). To
summarize, neither the common-effect model nor the random-effects model reports
a significant result. Nevertheless, we note that the fixed-effects model with the L-M
estimator reports a significant result (MD = -41.35, CI = -82.35 to -0.35), which
may not be very reasonable. Fortunately, the fixed-effects model with our optimal
estimator leads to the same non-significant result as the common-effect model and
the random-effects model (MD = -33.69, CI = -67.51 to 0.13), which is close to the
estimate of the mean effect in the random-effects model.
4.2 Meta-analysis with three studies
The first example is with Armitage et al. (2019). The authors reported a system-
atic review about the efficacy and safety of statin therapy in older people, with the
observed effect sizes being the risk ratios (RR). In a subgroup of effects on major vas-
cular events per mmol/L reduction in LDL cholesterol, subdivided by the age larger
than 75, only three studies are included for meta-analysis as shown in Figure 6(a).
The first two studies both report non-significant results (study 1: RR = 0.95, CI
= 0.82 to 1.11; study 2: RR = 0.95, CI = 0.81 to 1.12), and third study shows a
significant result (RR = 0.77, CI = 0.75 to 0.80). Combining the three studies, the
common-effect model gives a significant result for the common effect (RR = 0.79, CI
= 0.77 to 0.81). Nevertheless, with the large heterogeneity among the three studies
(I2 = 88%, p < 0.001), the meta-analytic results based on a common effect assump-
tion may be misleading in practice. On the other hand, the random-effects model
does not show a significant result for the mean effect with a wide CI (RR = 0.88,
CI = 0.74 to 1.04). Compared to the two models, the fixed-effects model provides
significant results for the unweighted average effect (the L-M estimator: RR = 0.89,
CI = 0.83 to 0.95; the optimal estimator: RR = 0.88, CI = 0.83 to 0.94), which is
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(a) Meta−analysis from Ding et al. (2018)
Study
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Figure 5: Meta-analyses with exactly two studies, where (a) represents the association
between the genetic variant rs1058205 in kallikrein 3 (KLK3) and prostate cancer risk,
and (b) represents the association between asthma and periodontal disease in adults.
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very close to the estimate of the mean effect in the random-effects model; and both
estimators yield narrower CIs for the unweighted average effect than that for the mean
effect in the random-effects model.
The second example is extracted from the systematic review to investigate the ef-
fectiveness of interventions for reducing nonoccupational sedentary behavior in adults
and older adults (Shrestha et al., 2019, Figure 6(b)). We address the outcomes in the
subgroup of the continuous outcomes, which includes only three studies. The observed
effect sizes in this meta-analysis are the mean differences (MD). Specifically, the first
study reports a non-significant result (MD = 5.8, CI = -7.77 to 19.37), the second
study also reports a significant result (MD = -14, CI = -20.36 to -7.64), and the third
study reports a non-significant result (MD = 6, CI = -10.64 to 22.64). Combining
the three studies, the common-effect model gives a significant result for the common
effect (MD = -8.68, CI = -14.12 to -3.23). Nevertheless, with the large heterogeneity
among the three studies (I2 = 80%, p < 0.005), the meta-analytic results from the
common-effect model may be misleading. In contrast, the random-effects model does
not offer a significant result for the mean effect (MD = -1.99, CI = -17.4 to 13.42). In
this example, we note that the fixed-effects model also show non-significant results by
both estimators (the L-M estimator: MD = -0.73, CI = -8.2 to 6.73; the optimal esti-
mator: MD = -1.45, CI = -8.49 to 5.59). Specifically, it provides a point estimate of
the unweighted average effect that is nearly the same as that for the mean effect in the
random-effects model (SMD = -1.99), and meanwhile it produces a much narrower CI
for the unweighted average effect than that for the mean effect in the random-effects
model. Note also that the optimal estimator has, once again, a slightly narrower CI
than the L-M estimator.
Based on the four real examples, we find that, based on different assumptions, the
three different models may have different summary effect estimates and conclusions.
The common-effect model should be avoided in the presence of heterogeneity. On the
other hand, the CI for the mean effect of the random-effects model is usually too wide
to be useful when the number of studies is small. The fixed-effects model tends to
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(a) Meta−analysis from Armitage et al. (2019)
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Figure 6: Meta-analyses with exactly three studies, where (a) represents the efficacy
and safety of statin therapy in older people, and (b) represents the effectiveness of
interventions for reducing nonoccupational sedentary behavior in adults and older
adults.
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have estimates of unweighted average effect close to the estimate of the mean effect in
the random-effects model with much narrower CIs. Therefore, they provide a more
meaningful summary for the effect sizes when the number of studies is small and the
heterogeneity is non-negligible.
5 Conclusion
Two commonly used models for meta-analysis, the common-effect model and the
random-effects model, both have their own limitations. The common-effect model
may lead to misleading results when the heterogeneity among studies cannot be ig-
nored. The CI for the mean effect based on the random-effects model may be too
wide to be useful when the number of studies is small. These limitations are major
obstacles in practice since a large portion of meta-analyses have small numbers of
studies with non-negligible heterogeneity. On the other hand, the fixed-effects model
not only avoids the unreasonable assumption on a common effect in the common-
effect model when the heterogeneity exists, but also avoids the low accuracy of the
between-study variance estimate in the random-effects model when there are only few
studies.
In this paper, we demonstrated that the fixed-effects model can serve as an alterna-
tive approach for meta-analysis under these situations with conclusions limited to the
observed studies. We also proposed an optimal estimator for the unweighted average
effect in the fixed-effects model that fully utilizes the information across the studies.
With a small increase in bias but a large reduction in variance, the optimal estimator
always has a smaller MSE than the existing estimator in the literature. Also as shown
in Figure 2, which quantity should be used as a summary effect in the fixed-effects
model is not immediately clear. Both the unweighted and weighted average effects
were proposed in the literature. The unweighted average effect treats each study as
equally important and is easy to interpret (Laird and Mosteller, 1990; Bender et al.,
2018). In contrast, the weighted average effect allows researchers to assign differ-
ent weights to different studies (Domínguez Islas and Rice, 2018; Rice et al., 2018).
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Which average effect to use for the fixed-effects model may depend on different factors
such as the goal of the meta-analysis and the sample sizes of different studies, and
may require further research.
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Appendix A
For the common-effect model, we consider the weighted average as an estimator of θ
as
θˆ =
k∑
i=1
wiyi,
where
∑k
i=1 wi = 1. It is evident that θˆ is an unbiased estimator of θ. Consequently,
the variance of θˆ will be the same as its MSE. Then with the Lagrange term, we have
f(w1, . . . , wk, λ) = MSE(θˆ)− λ(
k∑
i=1
wi − 1)
= E(
k∑
i=1
wiyi − θ)
2 − λ(
k∑
i=1
wi − 1)
=
k∑
i=1
wi
2σ2i − λ(
k∑
i=1
wi − 1),
where λ is a Lagrange multiplier to enforce the constraint
∑k
i=1 wi− 1 = 0. To derive
the study-specific weights, we take the first derivatives and set them to zero,
∂
∂wi
f(w1, . . . , wk, λ) = 2σ
2
iw
∗
i − λ = 0, i = 1, . . . , k,
we have wi = λ/2σ
2
i for i = 1, . . . , k. Combining it with
∂
∂λ
f(w1, . . . , wk, λ) =∑k
i=1 wi − 1 = 0, we have λ = 2/(
∑k
i=1 1/σ
2
i ) and wi = (1/σ
2
i )/(
∑k
i=1 1/σ
2
i ). Finally,
we have
θˆ =
∑k
i=1 w
C
i yi∑k
i=1 w
C
i
,
where wCi = 1/σ
2
i for i = 1, . . . , k.
Appendix B
For the random-effects model, we also consider the weighted average as an estimator
of µ as
µˆ =
k∑
i=1
wiyi,
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where
∑k
i=1 wi = 1. It is evident that µˆ is an unbiased estimator of µ. Consequently,
the variance of µˆ will be the same as its MSE. Then with the Lagrange term, we have
f(w1, . . . , wk, λ) = MSE(µˆ)− λ(
k∑
i=1
wi − 1)
= E(
k∑
i=1
wiyi − µ)
2 − λ(
k∑
i=1
wi − 1)
=
k∑
i=1
wi
2(σ2i + τ
2)− λ(
k∑
i=1
wi − 1),
where λ is a Lagrange multiplier to enforce the constraint
∑k
i=1 wi− 1 = 0. To derive
the study-specific weights, we take the first derivatives and set them to zero,
∂
∂wi
f(w1, . . . , wk, λ) = 2(σ
2
i + τ
2)wi − λ = 0, i = 1, . . . , k,
we have wi = λ/2(σ
2
i + τ
2) for i = 1, . . . , k. Combining it with ∂
∂λ
f(w1, . . . , wk, λ) =∑k
i=1 wi − 1 = 0, we have λ = 2/(
∑k
i=1 1/(σ
2
i + τ
2)). Finally, we have
µˆ =
∑k
i=1 w
R
i yi∑k
i=1 w
R
i
,
where wRi = 1/(σ
2
i + τ
2) for i = 1, . . . , k.
Appendix C
For the fixed-effects model, we consider the weighted average φ˜u =
∑k
i=1 wiyi as an
estimator of φu =
∑k
i=1 θi/k. To solve the optimal weights, we have
min f(w1, . . . , wk), s.t.
k∑
i=1
wi − 1 = 0; wj ≥ 0, j = 1, . . . , k, (10)
where
f(w1, . . . , wk) = MSE(φ˜u)
= E(
k∑
i=1
wiyi − φu)
2
=
k∑
i=1
wi
2σ2i + (
k∑
i=1
wiθi)
2 − 2
k∑
i=1
wiφuθi + φ
2
u.
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Note that for any two different vectors, w = (w1, . . . , wk) and w
∗ = (w∗1, . . . , w
∗
k), and
for any 0 < t < 1, we have
f((1− t)w + tw∗)− (1− t)f(w)− tf(w∗)
= t(t− 1)

 k∑
i=1
σ2i (wi − w
∗
i )
2 +
[
k∑
i=1
θi(wi − w
∗
i )
]2
< 0,
which means that f(w1, . . . , wk) is a strictly convex function. Thus the quadratic pro-
gramming problem (10) has a unique global minima for the feasible region {w|
∑k
i=1 wi−
1 = 0; wj ≥ 0, j = 1, . . . , k}; and the sufficient and necessary condition of w being
the global minima is that w satisfies the Karush-Kuhn-Tucker (KKT) conditions as
follows:
∂
∂wi
L(w1, . . . , wk, λ, µ1, . . . , µk) = 0,
k∑
j=1
wj − 1 = 0,
wi ≥ 0,
µi ≥ 0,
µiwi = 0,
(11)
for i = 1, . . . , k. The Lagrangian function L(w1, . . . , wk, λ, µ1, . . . , µk) is given as
L(w1, . . . , wk, λ, µ1, . . . , µk) = f(w1, . . . , wk) + λ(1−
k∑
i=1
wi)−
k∑
i=1
µiwi
=
k∑
i=1
wi
2σ2i + (
k∑
i=1
wiθi)
2 − 2
k∑
i=1
wiφuθi + φ
2
u
+ λ(1−
k∑
i=1
wi)−
k∑
i=1
µiwi,
where λ and µi are Lagrange multipliers to enforce the constraints.
When the quadratic programming problem (10) has an interior solution, which
means wi > 0 and µi = 0 for i = 1, . . . , k, there exists an explicit solution under the
KKT conditions:
λ =
2 + 2(
∑k
j=1 wjθj − φu)
∑k
j=1
θj
σ2
j∑k
j=1
1
σ2
j
,
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and
wi = ai − aibiφu + aibi
k∑
j=1
wjθj ,
where ai = σ
−2
i /(
∑k
j=1 σ
−2
j ) and bi =
∑k
j=1(θj − θi)σ
−2
i . For each i, we have one
equation with k variables for i = 1, . . . , k. Then we can solve all the wi with k
equations as
Aw = B,
where w = (w1, . . . , wk)
T , B = (a1b1φu − a1, . . . , akbkφu − ak)
T , and
A =


a1b1θ1 − 1 a1b1θ2 . . . a1b1θk
a2b2θ1 a2b2θ2 − 1 . . . a2b2θk
...
...
. . .
...
akbkθ1 . . . akbkθk−1 akbkθk − 1

 .
The unique solution is given as
wi =
1
σ2
i
(
1 +
∑k
j=1
(θj−θi)(θj−φu)
σ2
j
)
∑k
j=1
1
σ2
j
(
1 +
∑k
l=1
(θl−θj)(θl−φu)
σ2
l
) ,
for i = 1, . . . , k. When 1+
∑k
j=1(θj − θi)(θj − φu)/σ
2
j > 0 for all i = 1, . . . , k, we have
φ˜u =
∑k
i=1 w
F
i yi∑k
i=1 w
F
i
,
and the positive weights are
wFi =
1
σ2i

1 + k∑
j=1
(θj − θi)(θj − φu)
σ2j

.
Note that the inequalities to guarantee the positivity are also the sufficient and neces-
sary condition that the quadratic programming problem (10) has an interior solution.
When the assumption 1 +
∑k
j=1(θj − θi)(θj − φu)/σ
2
j > 0 does not hold for some
i = 1, . . . , k, there is no explicit solution for the optimal weights. In such settings,
the computational methods such as interior point and conjugate gradient can be used
to find the numerical solutions.
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